Sangeetha Venugopal, MD, MS, discussed the evolving landscape of acute myeloid leukemia treatment as well as unmet needs ...
2.3 The AP-1 and RUNX1 axis drives cell cycle progression and is essential for acute myeloid leukemia development Figure 6. Impact of AP-1 on gene expression. Model explaining how different ...
According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...
The researchers suggest certain refinements to the 2022 European LeukemiaNet classification model for patients aged 60 years ...
ICT01 showed tolerable safety and promising clinical activity as a monotherapy and is now being investigated in combination ...
News Medical on MSN4d
Innovative triplet therapy shows encouraging results in advanced chronic myeloid leukemiaAccording to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors AML is a genetically heterogeneous disease, ...
Working to drive significant value creation with INB-100 for AML; ongoing trial is actively enrolling additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback